Novavax says COVID vaccine for US to be manufactured by SII
"All vaccines that are being distributed globally commercially are being made in a single facility by our partners (the Serum Institute in India) that includes the vaccines which are being deployed around the world as well as the ones that will be initially deployed in the US," said Chief Medical Officer Filip Dubovsky
Novavax said that its COVID-19 vaccine initially available in the US, if authorised, will be manufactured by the Serum Institute of India (SII).
“So, all vaccines that are being distributed globally commercially are being made in a single facility by our partners (the Serum Institute in India) that includes the vaccines which are being deployed around the world as well as the ones that will be initially deployed in the US,” said Filip Dubovsky, Chief Medical Officer.
- Advertisement -